Pay in 4 interest-free payments of $7.44 Learn more
Ships within 48 hours · Estimated delivery Aug 29 - Sep 3
Brand-name Wegovy and Zepbound are sometimes covered for patients with documented obesity (BMI 30+) or BMI 27+ with a comorbid condition
Clinical Research Data: The Average Number of Pounds Dropped In a notable number of medical case studies and reviews, the effectiveness of AOM has proven to rival bariatric surgery results
Tirzepatide Once Weekly for the Treatment of Obesity | New England Journal of Medicine Note: the FDA considers body composition metrics to be safety endpoints which often results in underpowered secondary endpoints in Phase 3 registration trials
Your clinician will review your current dosage and adjust your overall treatment plan accordingly
)
/assets/images/provider/photos/2787796.jpeg)
